The trading price of Cognition Therapeutics Inc (NASDAQ:CGTX) floating higher at last check on current market day and closing at $0.43, 2.50% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.4201 and $0.4409. In examining the 52-week price action we see that the stock hit a 52-week high of $2.95 and a 52-week low of $0.34. Over the past month, the stock has lost -16.47% in value.
Cognition Therapeutics Inc, whose market valuation is $20.24 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest CGTX has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CGTX a recommendation rating is 3. Out of them, 0 rate it a Hold, while 3 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Cognition Therapeutics Inc (CGTX) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that CGTX’s price is currently -1.75% off the SMA20 and -6.00% off the SMA50. The RSI metric on the 14-day chart is currently showing 47.83, and weekly volatility stands at 6.34%. When measured over the past 30 days, the indicator reaches 9.03%. Cognition Therapeutics Inc (NASDAQ:CGTX)’s beta value is currently sitting at 1.25, while the Average True Range indicator is currently displaying 0.04.
To see how Cognition Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: CGTX stock’s performance was 2.50% at last check in today’s session, and -69.40% in the past year.
An evaluation of the daily trading volume of Cognition Therapeutics Inc (NASDAQ:CGTX) indicates that the 3-month average is 1.43 million. However, this figure has increased over the past 10 days to an average of 6.29.
Currently, records show that 40.81 million of the company’s shares remain outstanding. The insiders hold 15.78% of outstanding shares, whereas institutions hold 10.36%. The stats also highlight that short interest as of 2024-10-31, stood at 0.82 million shares, resulting in a short ratio of 1.07 at that time. From this, we can conclude that short interest is 294.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 0.53 million. However, since the stock’s price has seen -76.51% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
